More Clarity Pharmaceuticals Ltd. news
Clarity Pharmaceuticals Ltd.ASX: CU6

Trading Halt

Mar 24, 2024 at 11:12 PM EDT · Issued by Clarity Pharmaceuticals Ltd.

Filed with ASX · Mar 24, 2024 at 11:12 PM EDT

On 6ix: 6ix.com/news/trading-halt-112

Clarity Pharmaceuticals Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Clarity Pharmaceuticals Ltd. on 6ix

In the deck

  • Clarity Pharmaceuticals — Investor Presentation (March 2024)47 slidesMar 26, 2024

Earlier from Clarity Pharmaceuticals

  • First participant treated in the last dose escalation cohortMar 21, 2024
  • Theranostic prostate cancer trial advances to multi-doseMar 15, 2024
  • Additional COBRA trial data resultsMar 5, 2024
  • S&P DJI Announces March 2024 Quarterly RebalanceMar 1, 2024
  • Initial COBRA resultsFeb 14, 2024

Later from Clarity Pharmaceuticals

  • Clarity launches $121 million equity raiseMar 25, 2024
  • Investor PresentationMar 25, 2024
  • Completion of Placement and Institutional Entitlement OfferMar 27, 2024
  • Despatch of Retail Entitlement Offer BookletApr 3, 2024
  • Successful Completion of Retail Entitlement OfferApr 24, 2024
All Clarity Pharmaceuticals news releases↗

Follow Clarity Pharmaceuticals into a list and get an email when it puts out news.

Follow Clarity Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer